Edwards Lifesciences ROA 2012-2025 | EW
Current and historical return on assets (ROA) values for Edwards Lifesciences (EW) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Edwards Lifesciences ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $1.37B | $13.27B | 10.36% |
| 2025-06-30 | $4.15B | $13.49B | 31.58% |
| 2025-03-31 | $4.18B | $13.02B | 34.03% |
| 2024-12-31 | $4.18B | $13.06B | 36.41% |
| 2024-09-30 | $4.16B | $12.97B | 39.45% |
| 2024-06-30 | $1.47B | $10.10B | 15.28% |
| 2024-03-31 | $1.41B | $9.74B | 15.09% |
| 2023-12-31 | $1.40B | $9.36B | 15.42% |
| 2023-09-30 | $1.43B | $9.37B | 16.21% |
| 2023-06-30 | $1.39B | $9.00B | 16.08% |
| 2023-03-31 | $1.49B | $8.65B | 17.51% |
| 2022-12-31 | $1.52B | $8.29B | 18.02% |
| 2022-09-30 | $1.46B | $8.64B | 17.17% |
| 2022-06-30 | $1.46B | $8.43B | 17.37% |
| 2022-03-31 | $1.54B | $8.42B | 18.80% |
| 2021-12-31 | $1.50B | $8.50B | 19.06% |
| 2021-09-30 | $1.48B | $8.16B | 19.53% |
| 2021-06-30 | $1.46B | $7.66B | 20.24% |
| 2021-03-31 | $0.85B | $7.21B | 12.30% |
| 2020-12-31 | $0.82B | $7.24B | 12.42% |
| 2020-09-30 | $0.79B | $6.80B | 12.32% |
| 2020-06-30 | $0.74B | $6.42B | 11.93% |
| 2020-03-31 | $1.11B | $6.08B | 18.39% |
| 2019-12-31 | $1.05B | $6.49B | 17.82% |
| 2019-09-30 | $0.77B | $5.97B | 13.86% |
| 2019-06-30 | $0.73B | $5.57B | 12.99% |
| 2019-03-31 | $0.77B | $5.47B | 13.66% |
| 2018-12-31 | $0.72B | $5.32B | 12.69% |
| 2018-09-30 | $0.71B | $5.96B | 12.33% |
| 2018-06-30 | $0.66B | $5.69B | 11.59% |
| 2018-03-31 | $0.56B | $5.83B | 10.13% |
| 2017-12-31 | $0.58B | $5.67B | 11.07% |
| 2017-09-30 | $0.75B | $5.49B | 14.96% |
| 2017-06-30 | $0.72B | $5.14B | 15.26% |
| 2017-03-31 | $0.66B | $4.78B | 14.86% |
| 2016-12-31 | $0.57B | $4.51B | 13.61% |
| 2016-09-30 | $0.55B | $4.34B | 13.55% |
| 2016-06-30 | $0.53B | $4.05B | 13.36% |
| 2016-03-31 | $0.52B | $3.85B | 13.38% |
| 2015-12-31 | $0.50B | $4.06B | 13.17% |
| 2015-09-30 | $0.46B | $3.88B | 12.78% |
| 2015-06-30 | $0.44B | $3.61B | 12.60% |
| 2015-03-31 | $0.87B | $3.49B | 25.54% |
| 2014-12-31 | $0.81B | $3.52B | 25.24% |
| 2014-09-30 | $0.78B | $3.35B | 25.82% |
| 2014-06-30 | $0.76B | $3.33B | 27.06% |
| 2014-03-31 | $0.31B | $2.65B | 11.92% |
| 2013-12-31 | $0.39B | $2.71B | 15.75% |
| 2013-09-30 | $0.40B | $2.53B | 17.17% |
| 2013-06-30 | $0.40B | $2.34B | 17.45% |
| 2013-03-31 | $0.37B | $2.30B | 16.84% |
| 2012-12-31 | $0.29B | $2.22B | 13.70% |
| 2012-09-30 | $0.27B | $2.20B | 12.84% |
| 2012-06-30 | $0.25B | $2.08B | 12.33% |
| 2012-03-31 | $0.24B | $2.00B | 11.94% |
| 2011-12-31 | $0.24B | $1.98B | 12.00% |
| 2011-09-30 | $0.24B | $1.98B | 12.44% |
| 2011-06-30 | $0.24B | $2.00B | 12.66% |
| 2011-03-31 | $0.24B | $1.93B | 13.31% |
| 2010-12-31 | $0.22B | $1.77B | 13.00% |
| 2010-09-30 | $0.20B | $1.73B | 12.27% |
| 2010-06-30 | $0.23B | $1.64B | 14.11% |
| 2010-03-31 | $0.22B | $1.60B | 13.87% |
| 2009-12-31 | $0.23B | $1.62B | 15.29% |
| 2009-09-30 | $0.22B | $1.60B | 15.17% |
| 2009-06-30 | $0.18B | $1.47B | 12.85% |
| 2009-03-31 | $0.17B | $1.36B | 12.54% |
| 2008-12-31 | $0.13B | $1.40B | 9.49% |
| 2008-09-30 | $0.11B | $1.38B | 7.94% |
| 2008-06-30 | $0.10B | $1.35B | 7.76% |
| 2008-03-31 | $0.10B | $1.31B | 7.52% |
| 2007-12-31 | $0.11B | $1.35B | 8.77% |
| 2007-09-30 | $0.12B | $1.30B | 9.35% |
| 2007-06-30 | $0.12B | $1.25B | 9.38% |
| 2007-03-31 | $0.12B | $1.25B | 9.45% |
| 2006-12-31 | $0.13B | $1.25B | 10.51% |
| 2006-09-30 | $0.15B | $1.24B | 12.00% |
| 2006-06-30 | $0.12B | $1.26B | 9.60% |
| 2006-03-31 | $0.10B | $1.24B | 7.97% |
| 2005-12-31 | $0.08B | $1.23B | 6.88% |
| 2005-09-30 | $0.07B | $1.15B | 5.91% |
| 2005-06-30 | $0.08B | $1.15B | 7.45% |
| 2005-03-31 | $0.10B | $1.12B | 8.64% |
| 2004-12-31 | $0.00B | $1.11B | 0.18% |
| 2004-09-30 | $0.00B | $1.07B | -0.46% |
| 2004-06-30 | $0.01B | $1.09B | 0.73% |
| 2004-03-31 | $0.00B | $1.10B | 0.28% |
| 2003-12-31 | $0.08B | $1.10B | 7.46% |
| 2003-09-30 | $0.08B | $1.07B | 7.92% |
| 2003-06-30 | $0.04B | $1.08B | 4.06% |
| 2003-03-31 | $0.05B | $1.04B | 5.18% |
| 2002-12-31 | $0.06B | $1.00B | 5.89% |
| 2002-09-30 | $0.05B | $0.92B | 5.40% |
| 2002-06-30 | $0.08B | $0.98B | 8.64% |
| 2002-03-31 | $0.00B | $0.97B | -0.31% |
| 2001-12-31 | $-0.01B | $0.98B | -1.09% |
| 2001-09-30 | $-0.01B | $0.96B | -1.15% |
| 2001-06-30 | $-0.02B | $1.01B | -2.13% |
| 2001-03-31 | $-0.28B | $1.10B | -24.87% |
| 2000-12-31 | $-0.27B | $1.11B | -23.07% |
| 2000-09-30 | $-0.24B | $1.11B | -18.86% |
| 2000-06-30 | $-0.24B | $1.12B | -23.95% |
| 2000-03-31 | $0.09B | $1.38B | 12.35% |
| 1999-12-31 | $0.08B | $1.44B | 22.83% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $49.401B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.511B | 27.63 |
| Intuitive Surgical (ISRG) | United States | $210.153B | 82.22 |
| IDEXX Laboratories (IDXX) | United States | $56.962B | 56.57 |
| IQVIA Holdings (IQV) | United States | $41.282B | 23.02 |
| Alcon (ALC) | Switzerland | $39.524B | 26.71 |
| Mettler-Toledo (MTD) | United States | $30.339B | 35.49 |
| DexCom (DXCM) | United States | $26.287B | 36.24 |
| STERIS (STE) | Ireland | $25.206B | 26.02 |
| Waters (WAT) | United States | $23.626B | 31.24 |
| Coloplast (CLPBY) | Denmark | $19.855B | 33.88 |
| Hologic (HOLX) | United States | $16.689B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.750B | 0.00 |
| Globus Medical (GMED) | United States | $12.644B | 26.54 |
| Penumbra (PEN) | United States | $12.627B | 88.83 |
| Masimo (MASI) | United States | $7.462B | 23.91 |
| Glaukos (GKOS) | United States | $6.486B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.358B | 20.20 |
| Teleflex (TFX) | United States | $4.986B | 7.94 |
| TransMedics (TMDX) | United States | $4.684B | 55.49 |
| LivaNova (LIVN) | United Kingdom | $3.517B | 19.00 |
| Alphatec Holdings (ATEC) | United States | $3.365B | 0.00 |
| Veracyte (VCYT) | United States | $3.323B | 37.87 |
| Integer Holdings (ITGR) | United States | $2.954B | 13.87 |
| Elekta AB (EKTAY) | Sweden | $2.377B | 22.24 |
| Artivion (AORT) | United States | $2.101B | 96.41 |
| UFP Technologies (UFPT) | United States | $1.986B | 26.22 |
| Nihon Kohden (NHNKY) | Japan | $1.934B | 16.88 |
| PROCEPT BioRobotics (PRCT) | United States | $1.834B | 0.00 |
| AxoGen (AXGN) | United States | $1.546B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.471B | 0.00 |
| IRadimed (IRMD) | United States | $1.259B | 59.97 |
| Integra LifeSciences Holdings (IART) | United States | $1.058B | 5.73 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.982B | 0.00 |
| SiBone (SIBN) | United States | $0.887B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.887B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.675B | 39.27 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.625B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.588B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.44 |
| NeuroPace (NPCE) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.459B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.448B | 12.38 |
| ClearPoint Neuro (CLPT) | United States | $0.424B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.380B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.365B | 60.82 |
| RxSight (RXST) | United States | $0.363B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.296B | 2.21 |
| CVRx (CVRX) | United States | $0.213B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.187B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.185B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.162B | 0.00 |
| Neuronetics (STIM) | United States | $0.142B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.141B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.139B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Solana (HSDT) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.098B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.083B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.09 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |